Phase II clinical trial of TS-1 + docetaxel (DTX) combination therapy (OGSG 0902) for geriatric patients with advanced / recurrent gastric cancer in the elderly.
Phase of Trial: Phase II
Latest Information Update: 21 Jan 2017
At a glance
- Drugs Docetaxel (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 21 Jan 2017 Status changed from active, no longer recruiting to completed.
- 21 Jan 2017 Primary endpoint ((Response Rate (RECIST)) has been met.
- 21 Jan 2017 Results presented at the 2017 Gastrointestinal Cancers Symposium